Pyrexar Medical

PYREXAR Medical is a pioneer and global market leader in the development and manufacturing of innovative and highly efficient hyperthermia systems, with an established global distribution network. PYREXAR Hyperthermia can triple the effective dose of ionizing radiation on cancerous tumors without increasing toxicity to healthy tissues. The PYREXAR HT system delivers therapeutic heating to cancerous tumors through non-invasive radiofrequency (RF) energy. Cancer cells, being hypoxic and having a low pH, are more susceptible to elevated temperatures. During HT treatment, the microenvironment of solid tumors is heated to approximately 42˚C (108˚F) to help destroy malignant cells while sparing healthy tissue.